Manufacturing

Feb 22, 2018
By BioPharm International Editors
Avid Bioservices will provide commercial manufacture of an enzyme replacement therapy by Roivant Sciences' Enzyvant subsidiary.
Feb 22, 2018
By BioPharm International Editors
The new training center, the Jefferson Institute for Bioprocessing, will prepare engineering students and industry professionals for the field of biologics manufacturing.
Feb 20, 2018
By BioPharm International Editors
The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.
Feb 12, 2018
By BioPharm International Editors
The companies have been awarded a collaborative grant of £1.9 million (US$2.6 million) from Innovate UK.
Feb 01, 2018
BioPharm International
Single-use technologies are starting to gain ground as capacity needs change, but industrywide adoption remains low.
Feb 01, 2018
BioPharm International
Greater clarity on the application of existing regulations will accelerate development of cell and gene therapies.
Feb 01, 2018
BioPharm International
Frustrated with high costs and drug shortages, hospitals adopt a DIY approach.
Feb 01, 2018
BioPharm International
As closure integrity testing moves from a probabilistic to a deterministic basis, designs are promoting improved control and reduced operator contact.
Feb 01, 2018
By BioPharm International Editors
A collaboration between The Centre for Process Innovation and The Roslin Institute aims to develop commercially viable and scalable methods of producing biologics using transgenic animals.
Jan 31, 2018
By BioPharm International Editors
The new Acquity Arc Bio System by Waters is specifically engineered to enable efficient transfer and improvement of bioseparation analytical methods.
native1_300x100
lorem ipsum